SCHEMBL8790357

SCHEMBL8790357

COc1ccc(CN(C)CCCSc2ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 3/20 0.54
▸ ABCB1 P08183 2/20 0.54
▸ MAPT P10636 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TP53 P04637 3/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ OPRM1 P35372 3/20 0.41
▸ TMEM97 Q5BJF2 3/20 0.41
▸ SIGMAR1 Q99720 3/20 0.41
▸ POLB P06746 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ KLKB1 P03952 1/20 0.38
▸ MCHR1 Q99705 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789798 0.94 ABCG2 (0.48) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8790077 0.93 ABCG2 (0.47) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789078 0.93 ABCG2 (0.47) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8788717 0.92 ABCG2 (0.57) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789457 0.90 ABCG2 (0.60) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8790168 0.90 ABCG2 (0.62) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8790765 0.89 ABCG2 (0.56) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789486 0.89 ABCG2 (0.61) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789648 0.89 ABCG2 (0.63) ABCG2ABCB1MAPTTP53OPRK1
SCHEMBL8789139 0.89 ABCG2 (0.58) ABCG2ABCB1MAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP claimed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US claimed
EP-0569380-A1 ACRIDINE DERIVATIVES. GLAXO LAB SA (FR) 1993-11-18 — — EP claimed
WO-1992012132-A1 ACRIDINE DERIVATIVES LABORATOIRES GLAXO S.A. (FR) 1992-07-23 — — WO claimed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP claimed
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback